Corient Private Wealth’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$200K Buy
5,284
+761
+17% +$32.1K ﹤0.01% 2570
2025
Q4
$234K Sell
4,523
-10,298
-69% -$629K ﹤0.01% 2563
2025
Q3
$1.1M Buy
14,821
+1,569
+12% +$115K ﹤0.01% 1388
2025
Q2
$1.01M Buy
13,252
+1,373
+12% +$98.8K ﹤0.01% 1359
2025
Q1
$829K Buy
11,879
+5,341
+82% +$370K ﹤0.01% 1360
2024
Q4
$400K Sell
6,538
-1,367
-17% -$89.3K ﹤0.01% 1738
2024
Q3
$468K Sell
7,905
-280
-3% -$15.4K ﹤0.01% 1774
2024
Q2
$465K Buy
8,185
+2,015
+33% +$124K ﹤0.01% 1686
2024
Q1
$381K Buy
6,170
+782
+15% +$45.1K ﹤0.01% 1770
2023
Q4
$257K Buy
+5,388
New +$218K ﹤0.01% 1947

Other funds holding NTNX

Corient Private Wealth's NTNX Position: Q1 2026 in Review

Corient Private Wealth increased its Nutanix (NTNX) stake by 17% in Q1 2026, buying an estimated $32.1K and bringing the position to 5,284 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2570.

Corient Private Wealth first reported a position in NTNX in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.1M in Q3 2025. 533 funds tracked by Wall St. Rank hold NTNX as of Q1 2026.

  • Corient Private Wealth held 5,284 shares of Nutanix worth $200K as of Q1 2026.
  • Corient Private Wealth bought 761 Nutanix shares in Q1 2026, an estimated $32.1K.
  • Nutanix made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2570 holding.
  • Corient Private Wealth first reported a position in Nutanix in Q4 2023 and has held it in 10 quarters since.
  • Corient Private Wealth's Nutanix position peaked at $1.1M in Q3 2025.
  • 533 funds tracked by Wall St. Rank held Nutanix as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.